
Breakthrough Device Designation and Cybersecurity
Breakthrough Device designation speeds FDA interaction but waives no cybersecurity requirement. Here is how Section 524B applies to Breakthrough devices in 2026.
Read articleEvery article in our archive tagged Section 524B.
Looking for a quick answer instead? The FDA medical device cybersecurity FAQ covers Section 524B scope, SBOMs, threat models, CR515 and GMLP, deficiencies, and postmarket duties.
Showing 12 of 45 articles tagged Section 524B · Page 2 of 4

Breakthrough Device designation speeds FDA interaction but waives no cybersecurity requirement. Here is how Section 524B applies to Breakthrough devices in 2026.
Read article
Cleared under Section 524B but skipping postmarket cybersecurity? Here's what statute, regs, and FDA enforcement actually say - across 510(k), De Novo, PMA, PDP, and HDE.
Read article
Q-Sub vs Pre-Sub for FDA cybersecurity: what they are, how they differ, and when to use a Pre-Submission to de-risk Section 524B threat models, SBOMs, and pen tests.
Read article
When to use an FDA Submission Issue Request after a qualifying hold letter, how to frame cybersecurity questions, and why the formal response deadline still applies.
Read article
Medical device pen testing under FDA vs EU MDR: the 5 FDA report elements, MDR Annex I §17.2/17.4, and how one report serves both submissions.
Read article
A five-source workflow (510(k), De Novo, PMA, MAUDE, FOIA) for mining FDA cybersecurity precedent by product code before a Section 524B filing.
Read article
The FDA PCCP guidance isn't AI-only. Use a predetermined change control plan for cybersecurity patches, firmware updates, and SBOM component swaps.
Read article
FDA AI device cybersecurity in 2026: the February 2026 premarket guidance, PCCPs, the draft AI guidance's 7 threats, and how to cover them under Section 524B.
Read article
FDA Section 524B applies to connected auto-injectors when the device constituent has software and any electronic interface, whether CDER or CDRH leads review.
Read article
How to document update cadence for an FDA §524B submission: the regular cycle and the out-of-cycle expedited path reviewers expect under §524B(b)(2)(B).
Read article
FDA Section 524B applies to any new premarket submission for a cyber device, including legacy platforms.
Read article
How SPDF activities map to IEC 62304 software lifecycle processes - the exact crosswalk FDA reviewers expect, where they overlap, and where 62304 falls.
Read article30-minute strategy session. No cost, no commitment - just answers from people who've shipped 275+ devices supported.